Lincocin

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Lincomycin hydrochloride monohydrate equivalent to 250 mg lincomycin base;  

Disponible desde:

Pharmacia Limited Company trading as Pharmacia

Designación común internacional (DCI):

Lincomycin hydrochloride monohydrate (=250 mg lincomycin base)

Dosis:

250 mg

formulario farmacéutico:

Capsule

Composición:

Active: Lincomycin hydrochloride monohydrate equivalent to 250 mg lincomycin base   Excipient: Lactose monohydrate Magnesium stearate Purified talc

Unidades en paquete:

Bottle, plastic, 1x24, 24 capsules

clase:

Prescription

tipo de receta:

Prescription

Fabricado por:

Pfizer Pharmaceuticals LLC

indicaciones terapéuticas:

indicated in the treatment of upper respiratory infections including tonsillitis, pharyngitis, otitis media, sinusitis, scarlet fever and as adjuvant therapy for diphtheria. Effectiveness in the treatment of mastoiditis would be anticipated.

Resumen del producto:

Package - Contents - Shelf Life: Bottle, plastic, - 24 capsules - 60 months from date of manufacture stored at or below 25°C - Bottle, plastic, - 100 capsules - 60 months from date of manufacture stored at or below 25°C

Fecha de autorización:

1969-12-31